Literature DB >> 34050178

Telomere biology disorders.

Michelle L W Kam1, Trang T T Nguyen2, Joanne Y Y Ngeow3,4.   

Abstract

Telomere biology disorders (TBD) are a heterogeneous group of diseases arising from germline mutations affecting genes involved in telomere maintenance. Telomeres are DNA-protein structures at chromosome ends that maintain chromosome stability; their length affects cell replicative potential and senescence. A constellation of bone marrow failure, pulmonary fibrosis, liver cirrhosis and premature greying is suggestive, however incomplete penetrance results in highly variable manifestations, with idiopathic pulmonary fibrosis as the most common presentation. Currently, the true extent of TBD burden is unknown as there is no established diagnostic criteria and the disorder often is unrecognised and underdiagnosed. There is no gold standard for measuring telomere length and not all TBD-related mutations have been identified. There is no specific cure and the only treatment is organ transplantation, which has poor outcomes. This review summarises the current literature and discusses gaps in understanding and areas of need in managing TBD.

Entities:  

Year:  2021        PMID: 34050178     DOI: 10.1038/s41525-021-00198-5

Source DB:  PubMed          Journal:  NPJ Genom Med        ISSN: 2056-7944            Impact factor:   8.617


  78 in total

Review 1.  The molecular genetics of the telomere biology disorders.

Authors:  Alison A Bertuch
Journal:  RNA Biol       Date:  2015-09-23       Impact factor: 4.652

2.  Telomere end-replication problem and cell aging.

Authors:  M Z Levy; R C Allsopp; A B Futcher; C W Greider; C B Harley
Journal:  J Mol Biol       Date:  1992-06-20       Impact factor: 5.469

3.  Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.

Authors:  Hiroki Yamaguchi; Rodrigo T Calado; Hinh Ly; Sachiko Kajigaya; Gabriela M Baerlocher; Stephen J Chanock; Peter M Lansdorp; Neal S Young
Journal:  N Engl J Med       Date:  2005-04-07       Impact factor: 91.245

4.  Cancer spectrum and outcomes in the Mendelian short telomere syndromes.

Authors:  Kristen E Schratz; Lisa Haley; Sonye K Danoff; Amanda L Blackford; Amy E DeZern; Christopher D Gocke; Amy S Duffield; Mary Armanios
Journal:  Blood       Date:  2020-05-28       Impact factor: 22.113

5.  A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis.

Authors:  C W Greider; E H Blackburn
Journal:  Nature       Date:  1989-01-26       Impact factor: 49.962

6.  From incomplete penetrance with normal telomere length to severe disease and telomere shortening in a family with monoallelic and biallelic PARN pathogenic variants.

Authors:  Lois M Dodson; Alessandro Baldan; Mikael Nissbeck; Sethu M R Gunja; Penelope E Bonnen; Geraldine Aubert; Sherri Birchansky; Anders Virtanen; Alison A Bertuch
Journal:  Hum Mutat       Date:  2019-09-15       Impact factor: 4.878

7.  X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions.

Authors:  N S Heiss; S W Knight; T J Vulliamy; S M Klauck; S Wiemann; P J Mason; A Poustka; I Dokal
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

8.  Identification of a specific telomere terminal transferase activity in Tetrahymena extracts.

Authors:  C W Greider; E H Blackburn
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

9.  Telomerase mutations in families with idiopathic pulmonary fibrosis.

Authors:  Mary Y Armanios; Julian J-L Chen; Joy D Cogan; Jonathan K Alder; Roxann G Ingersoll; Cheryl Markin; William E Lawson; Mingyi Xie; Irma Vulto; John A Phillips; Peter M Lansdorp; Carol W Greider; James E Loyd
Journal:  N Engl J Med       Date:  2007-03-29       Impact factor: 91.245

Review 10.  An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.

Authors:  Marena R Niewisch; Sharon A Savage
Journal:  Expert Rev Hematol       Date:  2019-09-10       Impact factor: 2.819

View more
  8 in total

Review 1.  Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.

Authors:  Himachandana Atluri; Yoheved S Gerstein; Courtney D DiNardo
Journal:  Curr Hematol Malig Rep       Date:  2022-10-24       Impact factor: 4.213

2.  TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis.

Authors:  John A Mackintosh; Maria Pietsch; Viviana Lutzky; Debra Enever; Sandra Bancroft; Simon H Apte; Maxine Tan; Stephanie T Yerkovich; Joanne L Dickinson; Hilda A Pickett; Hiran Selvadurai; Christopher Grainge; Nicole S Goh; Peter Hopkins; Ian Glaspole; Paul N Reynolds; Jeremy Wrobel; Adam Jaffe; Tamera J Corte; Daniel C Chambers
Journal:  BMJ Open Respir Res       Date:  2021-12

3.  Gain-of-function mutations in RPA1 cause a syndrome with short telomeres and somatic genetic rescue.

Authors:  Richa Sharma; Sushree S Sahoo; Masayoshi Honda; Sophie L Granger; Charnise Goodings; Louis Sanchez; Axel Künstner; Hauke Busch; Fabian Beier; Shondra M Pruett-Miller; Marcus B Valentine; Alfonso G Fernandez; Ti-Cheng Chang; Vincent Géli; Dmitri Churikov; Sandrine Hirschi; Victor B Pastor; Melanie Boerries; Melchior Lauten; Charikleia Kelaidi; Megan A Cooper; Sarah Nicholas; Jill A Rosenfeld; Sophia Polychronopoulou; Caroline Kannengiesser; Carole Saintomé; Charlotte M Niemeyer; Patrick Revy; Marc S Wold; Maria Spies; Miriam Erlacher; Stéphane Coulon; Marcin W Wlodarski
Journal:  Blood       Date:  2022-02-17       Impact factor: 22.113

4.  Utility of Telomerase Gene Mutation Testing in Patients with Idiopathic Pulmonary Fibrosis in Routine Practice.

Authors:  Julij Šelb; Katarina Osolnik; Izidor Kern; Peter Korošec; Matija Rijavec
Journal:  Cells       Date:  2022-01-22       Impact factor: 6.600

Review 5.  Non-Melanoma Skin Cancers and Other Cutaneous Manifestations in Bone Marrow Failure Syndromes and Rare DNA Repair Disorders.

Authors:  Jennie Vagher; Amanda Gammon; Wendy Kohlmann; Joanne Jeter
Journal:  Front Oncol       Date:  2022-03-10       Impact factor: 6.244

Review 6.  Genetics and genomics of bone marrow failure syndrome.

Authors:  Hyun-Young Kim; Hee-Jin Kim; Sun-Hee Kim
Journal:  Blood Res       Date:  2022-04-30

7.  Single Nucleotide Polymorphisms (SNP) and SNP-SNP Interactions of the Surfactant Protein Genes Are Associated With Idiopathic Pulmonary Fibrosis in a Mexican Study Group; Comparison With Hypersensitivity Pneumonitis.

Authors:  Ata Abbasi; Chixiang Chen; Chintan K Gandhi; Rongling Wu; Annie Pardo; Moises Selman; Joanna Floros
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

8.  A Rare Heterozygous TINF2 Deletional Frameshift Mutation in a Chinese Pedigree With a Spectrum of TBDs Phenotypes.

Authors:  Hai-Long Ren; Ying-Chun Zheng; Guo-Qian He; Ju Gao; Xia Guo
Journal:  Front Genet       Date:  2022-07-07       Impact factor: 4.772

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.